Merlin Capital, Inc - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 279 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.

Quarter-by-quarter ownership
Merlin Capital, Inc ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$585,792
-18.6%
18,526
+5.0%
2.19%
-10.1%
Q2 2023$719,400
+53.1%
17,641
+39.9%
2.44%
+42.8%
Q1 2023$469,975
+9.5%
12,610
+2.5%
1.70%
+61.5%
Q4 2022$429,252
-34.2%
12,303
+5.5%
1.06%
-30.1%
Q3 2022$652,000
+3.5%
11,657
-4.2%
1.51%
+19.7%
Q2 2022$630,000
-25.1%
12,174
+5.2%
1.26%
+13.6%
Q1 2022$841,000
+8.5%
11,575
+76.6%
1.11%
+23.9%
Q4 2021$775,0006,5550.90%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders